S
Stephen P. Peters
Researcher at Wake Forest University
Publications - 329
Citations - 25290
Stephen P. Peters is an academic researcher from Wake Forest University. The author has contributed to research in topics: Asthma & COPD. The author has an hindex of 74, co-authored 302 publications receiving 22503 citations. Previous affiliations of Stephen P. Peters include Cleveland Clinic & Research Medical Center.
Papers
More filters
Journal ArticleDOI
Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program
Wendy C. Moore,Deborah A. Meyers,Sally E. Wenzel,W. Gerald Teague,Huashi Li,Xingnan Li,Ralph B. D'Agostino,Mario Castro,Douglas Curran-Everett,Anne M. Fitzpatrick,Benjamin Gaston,Nizar N. Jarjour,Ronald L. Sorkness,William J. Calhoun,Kian Fan Chung,Suzy A.A. Comhair,Raed A. Dweik,Elliot Israel,Stephen P. Peters,William W. Busse,Serpil C. Erzurum,Eugene R. Bleecker +21 more
TL;DR: Five distinct clinical phenotypes of asthma have been identified using an unsupervised hierarchical cluster analysis, which supports clinical heterogeneity in asthma and the need for new approaches for the classification of disease severity in asthma.
Journal ArticleDOI
Proceedings of the ATS Workshop on Refractory Asthma Current Understanding, Recommendations, and Unanswered Questions
Sally E. Wenzel,John V. Fahy,Charles G. Irvin,Stephen P. Peters,Sheldon L. Spector,Stanley J. Szefler,Thomas B. Casale,Michelle M. Cloutier,Jack A. Elias,Mark C. Liu,Virginia Taggert +10 more
TL;DR: The proceedings of an American Thoracic Society (ATS)-sponsored workshop are hoped to serve as an aid to begin to define, understand, and manage these refractory patients.
Journal ArticleDOI
Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program
Wendy C. Moore,Eugene R. Bleecker,Douglas Curran-Everett,Serpil C. Erzurum,Bill T. Ameredes,Leonard B. Bacharier,William J. Calhoun,Mario Castro,Kian Fan Chung,Melissa P. Clark,Raed A. Dweik,Anne M. Fitzpatrick,Benjamin Gaston,Mark Hew,Iftikhar Hussain,Nizar N. Jarjour,Elliot Israel,Bruce D. Levy,James Murphy,Stephen P. Peters,W. Gerald Teague,Deborah A. Meyers,William W. Busse,Sally E. Wenzel,Sally E. Wenzel,Sally E. Wenzel +25 more
TL;DR: Severe asthma is characterized by abnormal lung function that is responsive to bronchodilators, a history of sinopulmonary infections, persistent symptoms, and increased health care utilization.
Journal ArticleDOI
Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.
Yvonne J. Huang,Craig E. Nelson,Eoin L. Brodie,Todd Z. DeSantis,Marshall S. Baek,Jane Liu,Tanja Woyke,Martin Allgaier,James Bristow,Jeanine P. Wiener-Kronish,E. Rand Sutherland,Tonya S. King,Nikolina Icitovic,Richard J. Martin,William J. Calhoun,Mario Castro,Loren C. Denlinger,Emily DiMango,Monica Kraft,Stephen P. Peters,Stephen I. Wasserman,Michael E. Wechsler,Homer A. Boushey,Susan V. Lynch +23 more
TL;DR: The composition of Bronchial airway microbiota is associated with the degree of bronchial hyperresponsiveness among patients with suboptimally controlled asthma, and these findings support the need for further functional studies to examine the potential contribution of members of theAirway microbiota in asthma pathogenesis.
Journal ArticleDOI
Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial
Elliot Israel,Vernon M. Chinchilli,Jean G. Ford,Homer A. Boushey,Reuben M. Cherniack,Timothy J. Craig,Aaron Deykin,Joanne K. Fagan,John V. Fahy,James E. Fish,Monica Kraft,Susan J. Kunselman,Stephen C. Lazarus,Robert F. Lemanske,Stephen B. Liggett,Richard J. Martin,Nandita Mitra,Stephen P. Peters,Eric S. Silverman,Christine A. Sorkness,Stanley J. Szefler,Michael E. Wechsler,Scott T. Weiss,Jeffrey M. Drazen +23 more
TL;DR: Genotype at the 16th aminoacid residue of the beta2-adrenergic receptor affects the long-term response to albuterol use and Bronchodilator treatments avoiding albutersol may be appropriate for patients with the Arg/Arg genotype.